The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Oramed Pharmaceuticals, Inc’s current trading price is -23.43% away from its 52-week high, while its distance from the 52-week low is 40.50%. The stock’s price range for this period has been between $2.00 and $3.67 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.89 million for the day, a number notably higher than the average daily volume of 0.16 million over the last three months.
Oramed Pharmaceuticals, Inc experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $3.67 on 02/27/24, while the lowest price for the same period was registered at $2.00 on 06/10/24.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Oramed Pharmaceuticals, Inc (ORMP) has experienced a quarterly rise of 18.07% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 113.28M and boasts a workforce of 15 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.36, with a change in price of +0.27. Similarly, Oramed Pharmaceuticals, Inc recorded 146,246 in trading volume during the last 100 days, posting a change of +10.79%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ORMP stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
ORMP Stock Stochastic Average
Oramed Pharmaceuticals, Inc’s raw stochastic average for the past 50 days is presently 97.18%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 97.18%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 43.89% and 29.49%, respectively.
ORMP Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price gain of 16.12% this year. Over the last six months, there has been a weaker performance of 20.09%. The price of ORMP fallen by 17.57% during the last 30 days period. For the last 5-days stocks have improved 28.31%.
